April 23rd, 2015

Voting Results from Johnson & Johnson’s Annual Meeting of Shareholders

By Doug Chia, Assistant General Counsel & Corporate Secretary, Johnson & Johnson

April 23rd, 2015 – Today, Johnson & Johnson held its 127th Annual Meeting of Shareholders in New Brunswick, NJ, returning to the State Theatre, where our Annual Meeting was held back in 1989. (Our Kilmer House blog has a nice piece about the history of the Johnson & Johnson Annual Meeting.)

Here is a recap of the official business from today’s meeting, including preliminary voting results:

1) Election of Directors: All 11 Director nominees were elected to serve one-year terms on the Board of Directors with the support of over 95 percent of the votes cast.  Alex Gorsky (Chairman/CEO) received the support of 96.6 percent.  A full list of our Board members, including their biographies, can be found in the Corporate Governance section of the investor.jnj.com website.

2) Advisory Vote to Approve Named Executive Officer Compensation: In this advisory vote, our shareholders approved the company’s executive compensation philosophy, policies and procedures and the compensation of the executive officers named in the 2015 Proxy Statement with the support of 95.1 percent of the votes cast.

3) Ratification of Appointment of Independent Registered Public Accounting Firm: Our shareholders approved the appointment of PricewaterhouseCoopers LLP to serve as our independent auditors for fiscal 2015 with the support of 98.8 percent of the votes cast.

Read More

April 22nd, 2015

Today’s Dreams for Tomorrow’s Nurses

By Andrea Higham, Senior Director, Corporate Equity, Johnson & Johnson

Earlier this month, the nurses of tomorrow brought their energy and enthusiasm for the profession to Phoenix for the 63rd Annual National Student Nurses’ Association (NSNA) convention. With a membership of 60,000, NSNA is the largest organization for students enrolled in associate, baccalaureate, diploma, and generic graduate nursing programs in the U.S. The convention brings together thousands of student nurses, faculty, and nursing leaders from across the country who look to foster their educational and professional development, and in the case of this year’s convention theme, seek out “bright horizons and rise to new opportunities.”

Class-of-2015

Since the Johnson & Johnson Campaign for Nursing’s Future began in 2002, we’ve been fully committed to support of tomorrow’s nurses, our nursing students. The Campaign contributes more than $500k annually to U.S. nursing scholarships and grant programs. And through “The Promise of Nursing” galas, the Campaign joins with local healthcare organizations, hospitals and schools to raise funds to support local nursing programs and students in their communities. Since these first began, we’ve hosted over 30 galas and these events have raised more than $19M. These galas are a wonderful way for us to work directly with a region’s healthcare community and leverage together the goals of the Campaign, strengthen healthcare and support students.

Read More

April 17th, 2015

Raising Brain Injury Awareness

By Dr. Husseini Manji, Global Head, Neuroscience, Janssen Research & Development

Editor’s Note: This weekend the Neuroscience Therapeutic Area at Janssen Research & Development, LLC, a Johnson & Johnson company, is hosting the 32nd Annual  Johnson & Johnson International Hockey Tournament, an event that supports education, awareness and research efforts into traumatic brain injuries and spinal cord injuries.

Janssen Hockey trophy

Photo Credit: Mark Krajnak

When we hear the word “concussion,” hockey clashes and car crashes often spring to mind.  Rightly so, but concussions and traumatic brain injuries can occur in a variety of other circumstances: when a child gets hurt in a ballgame, an elderly person falls, or an explosion injures a soldier.

Concussions and traumatic brain injuries occur when a blow, violent jolt or penetration to the head disrupts brain function. According to the CDC’s Report to Congress on Traumatic Brain Injury Epidemiology and Rehabilitation, in one year in the U.S., traumatic brain injuries resulted in 50,000 deaths and 2.2 million emergency room visits. According to American Academy of Neurology, more than one million men and women athletes in the U.S. experience a concussion annually.

But the statistics tell only a fraction of the story. The neurological effects of head injuries have the potential to set in motion behavioral, emotional and physical disabilities.

Read More

April 15th, 2015

Being the Spark that Ignites Innovation

Editor’s Note: At Johnson & Johnson, we occasionally like to share an ‘inside out’ perspective about our company and our employees. Recently, Martin Madden, Vice President of Research & Development and Innovation for Global Surgery, spoke at the Johnson & Johnson Global Surgery Research & Development Conference, an annual meeting of hundreds of colleagues who work in Global Surgery around the world. With the theme ‘Ignite Innovation,’ this meeting maintains a tradition that had taken place for nearly 70 years. We invite you to read excerpts of Martin’s remarks about how igniting innovation enhances our ability to address the needs of the patients we serve.

Martin’s remarks:

Welcome to Global Surgery Innovation Day 2015! Let’s talk for a minute about this year’s theme: Igniting Innovation. The theme speaks to so many elements of what we do. Historically, much of the Innovation we foster happens over the course of time.  Our internal teams work closely with our physician partners to enhance and improve upon our products and technology platforms. This step-wise approach to innovation is a significant driver of growth. Most important, it is a major enabler in our ability to advance our portfolio and address the evolving needs of the patients we are all so privileged to serve.

Read More

April 9th, 2015

Five Questions for Know Your Value Creator Mika Brezezinski

Editor’s Note: Johnson & Johnson is a proud sponsor of the Know Your Value tour, a nationwide effort focused on empowering women to express their worth in business and in life, based on the book, Knowing Your Value by best-selling author and Co-host of Morning Joe, Mika Brezezinski. J&J recently spoke with Mika to find out more about her book, her tour, and the Know Your Value movement.

Mika Brezezinski

Q: What led you to start the Know Your Value movement? 

A: This message is personal for me. It took me 25 years to understand that I played a role in quantifying my success. For too many years, I let others do the talking and made the same mistakes time and time again. Over the past five years, I have been studying and writing about this in my books including Knowing Your Value as well as my upcoming book Grow Your Value. I have drawn from the most important voices on this topic. Through all of this, I’ve made significant changes in my own life as well which I look forward to sharing with all of you.

Q: Why do women in particular seem to lose their voice when it comes to advocating for themselves at work and in life?

Read More

April 2nd, 2015

The First Tee Helps Lead Youth to a Brighter Future

Editor’s Note: As part of its longstanding commitment to children, Johnson & Johnson is the first Legacy Partner of The First Tee. The First Tee provides educational programs that build character, instill life-enhancing values and promote healthy choices through the game of golf. Today, we shine a spotlight on several current and former Johnson & Johnson employees who have volunteered their time with The First Tee and have seen firsthand how its programs positively impact children.

Al-Mays-First-Tee

It’s tee time and Johnson & Johnson retiree Alfred Mays is set to enjoy the hobby he’s picked up in retirement – just not with the foursome you might expect. As an assistant coach and mentor with The First Tee of Savannah in Georgia, Alfred’s time on the course is often spent with young people who are learning life skills and leadership through the game of golf.

“I clearly see kids who have much more confidence in school, out of school and in work environments, based on their experience interacting with adults in The First Tee,” says Alfred, who retired in 2006 after 37 years with Johnson & Johnson. “The kids grow by leaps and bounds when they see that somebody cares about them and shares what the values learned in golf might mean as they get older.”

With The First Tee, Alfred found an incredible opportunity to combine his passion for the game of golf with his professional experience.

Read More

March 30th, 2015

In Motion at the American Academy of Orthopaedic Surgeons Meeting

By Michel Orsinger, Worldwide Chairman, Global Orthopaedics Group

I often say that the human body is meant to be in motion.

This week, the amazing technologies that make that possible, and the dedicated men and women who apply those technologies in orthopaedic surgery, were out in force at the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS). DePuy Synthes was proud to be there as the world’s largest and most comprehensive orthopaedics company.

Three essential components work to keep bodies in motion: innovative solutions, dedicated surgeons, and supportive healthcare systems. Our DePuy Synthes Value Proposition recognizes the importance of each of them.

We brought INNOVATION to the AAOS meeting in the form of new products like TFN Advanced™ Femoral Nailing System, an advanced surgical nail system that helps patients who have fractured their hips. But we know it takes innovation beyond products, too. For example, we introduced surgeons to CareSense, an application that can help track patients’ progress throughout the orthopaedic treatment cycle. Every day, we bring innovation to hospital systems as we work to address the needs of surgeons as well as the cost and outcomes goals of healthcare networks.

2015 American Academy of Ortho

DePuy Synthes booth displays at the 2015 American Academy of Orthopaedic Surgeons meeting

This is the largest global meeting of orthopaedic surgeons each year – thousands and thousands of surgeons, many from outside the United States, come to participate in education and networking, and to see the new advances the orthopaedic industry is developing.

Read More

March 26th, 2015

#MuseumWeek and the Importance of Heritage

By Margaret Gurowitz, Chief Historian, Johnson & Johnson

#MuseumWeekThis week, thousands of museums and their fans across the world are celebrating #Museum Week. It’s an opportunity to use social media to engage people and get them excited about museums. Johnson & Johnson is proud to participate this year for the first time.

As the chief historian for Johnson & Johnson – and as a lifelong museum nerd – it’s not difficult to get me started on talking about the rich history of Johnson & Johnson and about our museum.   Since Johnson & Johnson was founded in 1886, our company has advanced health care and helped shape the modern world through innovations such as helping make surgery sterile, the first commercial first aid kits (1888) and first aid manuals (1901), trusted consumer products and maternal and child health kits to make childbirth safer (1894), the first premade commercial dressing for small wounds (1921), breakthrough medicines, community programs and much, much more.  Understanding our history is one of the best ways to understand Johnson & Johnson and the values that guide our company.

But our heritage is more than just a look back at the past: it’s a look at our present and future too.

Read More

March 25th, 2015

The Yin and Yang of Technology and Healthcare

By Kris Sterkens, Company Group Chairman, Janssen, the pharmaceutical companies of Johnson & Johnson, Asia Pacific

Earlier this month in Singapore, I had the privilege of speaking at the Healthcare Innovation Summit Asia, an annual event that evaluates the value of technology in improving health outcomes for our region. Both science and technology continue to have a positive impact on our lives while converging on so many levels, so it was a valuable opportunity to explore how this interconnectivity can deliver innovative solutions that address unmet medical needs.

Big Data is enabling our industry to process large amounts of unstructured data more efficiently than ever before, which is allowing our researchers to more quickly identify connections, causes and effects. We’re also seeing more opportunities with wearable devices to help patients manage chronic diseases. In Australia, we are partnering with a local company on the development of a wearable device to help predict falls in the elderly before they occur. As well as helping patients, this has the potential to reduce the enormous annual cost burden for injuries that are caused by falls in Australia.

But in an era defined by profound technological advances, the practice of medicine remains an art as well as a science.

Read More

March 24th, 2015

An End-to-End Approach to Advancing Medical Innovation

Last week, Dr. William Hait, Global Head, Janssen Research & Development, and  Member of the Research!America Board, published a guest blog post on ResearchAmerica.org where he underscored the importance of collaborating with key stakeholders to form an end-to-end approach to enhance critically needed research.

Dr. Hait emphasized that “solving complex research challenges requires more than individual effort. It also takes the willingness and skill to bring together government, academia and the private sector.”

He noted that innovative approaches that enhance the speed of medical innovation, combined with more robust U.S. federal funding of health research and new STEM education initiatives, “form an end-to-end approach that will enhance critically needed research, fostering a new generation of R&D talent, and incentivizing development of next-generation technologies. Collectively, they will help advance medical innovation for all to benefit.”

Read the full blog post here.


Bill HaitWilliam N. Hait is Global Head, Janssen Research & Development, LLC, the global research and development arm of Janssen, the pharmaceutical companies of Johnson & Johnson. In this role, he leads the global R&D group in its mission to discover and develop innovative new medicines to address the world’s most serious unmet medical needs.

Read More